Literature DB >> 18621629

Hypertrophic osteoarthropathy effectively treated with zoledronic acid.

Melissa M King1, Douglas A Nelson.   

Abstract

Hypertrophic osteoarthropathy (HOA) is a syndrome characterized by digital clubbing, arthralgias, and tissue swelling and is frequently described in association with bronchogenic carcinoma. The associated pain can be disabling, and symptoms are often resistant to conventional analgesic medications. We present a patient with HOA of the lower extremities and wrists that developed after bronchogenic carcinoma. The pain and swelling completely resolved after a single administration of 4 mg of zoledronic acid. The proposed pathogenesis of HOA and the mechanisms by which bisphosphonates might alleviate symptoms are reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621629     DOI: 10.3816/CLC.2008.n.027

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  11 in total

Review 1.  [Hypertrophic osteoarthropathy. Bamberger-Marie disease].

Authors:  B Manger; A Lindner; K Manger; J Wacker; G Schett
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

2.  Hypertrophic osteoarthropathy: Detecting periosteal inflammation using Doppler ultrasound.

Authors:  Nobuya Abe; Hideki Kasahara; Takao Koike
Journal:  Eur J Rheumatol       Date:  2017-10-25

3.  A case report of disabling bone pain after long-term kidney transplantation.

Authors:  T M M Myint; M Vucak-Dzumhur; P R Ebeling; G J Elder
Journal:  Osteoporos Int       Date:  2013-06-26       Impact factor: 4.507

Review 4.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.

Authors:  Sebastian G Bernardo; Jason J Emer; Mark E Burnett; Marsha Gordon
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

6.  Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience.

Authors:  Nikhil Sonthalia; Kabita Mukherjee; Avishek Saha; Arunansu Talukdar
Journal:  BMJ Case Rep       Date:  2012-11-11

Review 7.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.

Authors:  Sheila Nguyen; Mehrnaz Hojjati
Journal:  Clin Rheumatol       Date:  2010-10-09       Impact factor: 2.980

8.  Lung carcinoma with hypertrophic osteoarthropathy in a teenager.

Authors:  Rowan E Miller; Rowland O Illing; Jeremy S Whelan
Journal:  Rare Tumors       Date:  2011-03-30

9.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

10.  A complicated case of pachydermoperiostosis with spondyloarthritides: a case report.

Authors:  Qing Zhang; Min Shen; Bo Yang; Keyi Yu
Journal:  J Med Case Rep       Date:  2013-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.